Showing 1 - 13 results of 13 for search 'Ross Andrews', query time: 0.06s Refine Results
  1. 1
    Convergence of surveillance blind spots with antimicrobial resistance hotspots

    Convergence of surveillance blind spots with antimicrobial resistance hotspots by Teresa M. Wozniak, Heidi Smith‐Vaughan, Ross Andrews

    Published 2021-12-01
    Get full text
    Article
  2. 2
    Outcomes Reported for Australian First Nation Populations for the Influenza A(H1N1) 2009 Pandemic and Lessons for Future Infectious Disease Emergencies: a Systematic Review

    Outcomes Reported for Australian First Nation Populations for the Influenza A(H1N1) 2009 Pandemic and Lessons for Future Infectious Disease Emergencies: a Systematic Review by Alana Gall, Charlee Law, Peter Massey, Kristy Crooks, Ross Andrews, Emma Field

    Published 2020-07-01
    Get full text
    Article
  3. 3
    Ongoing symptoms and functional impairment 12 weeks after testing positive for SARS-CoV-2 or influenza in Australia: an observational cohort study

    Ongoing symptoms and functional impairment 12 weeks after testing positive for SARS-CoV-2 or influenza in Australia: an observational cohort study by Matthew Brown, Ross Andrews, John Gerrard, Lynne McKinlay, John Marquess, Teneika Sparrow

    Published 2023-12-01
    Get full text
    Article
  4. 4
    Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition.

    Community management of endemic scabies in remote aboriginal communities of northern Australia: low treatment uptake and high ongoing acquisition. by Sophie La Vincente, Therese Kearns, Christine Connors, Scott Cameron, Jonathan Carapetis, Ross Andrews

    Published 2009-01-01
    Get full text
    Article
  5. 5
    Planning for and responding to pandemic influenza emergencies: it’s time to listen to, prioritize and privilege Aboriginal perspectives

    Planning for and responding to pandemic influenza emergencies: it’s time to listen to, prioritize and privilege Aboriginal perspectives by Kristy Crooks, Peter D Massey, Kylie Taylor, Adrian Miller, Sandra Campbell, Ross Andrews

    Published 2019-11-01
    Get full text
    Article
  6. 6
    Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution

    Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution by Kristy Crooks, Kylie Taylor, Kiara Burns, Sandy Campbell, Chris Degeling, Jane Williams, Ross Andrews, Peter Massey, Jodie McVernon, Adrian Miller

    Published 2023-11-01
    Get full text
    Article
  7. 7
    The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis

    The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous in... by Jonathan Carapetis, Tom Snelling, Mark A Jones, Julie A Marsh, Bianca Fleur Middleton, Claire S Waddington, Margaret Danchin, Carly McCallum, Sarah Gallagher, Ross Andrews, Carl Kirkwood, Nigel Cunliffe

    Published 2019-11-01
    Get full text
    Article
  8. 8
    Defining the need for public health control of scabies in Solomon Islands.

    Defining the need for public health control of scabies in Solomon Islands. by Susanna J Lake, Daniel Engelman, Oliver Sokana, Titus Nasi, Dickson Boara, Anneke C Grobler, Millicent H Osti, Ross Andrews, Michael Marks, Margot J Whitfeld, Lucia Romani, John M Kaldor, Andrew C Steer

    Published 2021-02-01
    Get full text
    Article
  9. 9
    Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study)

    Protocol for a cluster-randomised non-inferiority trial of one versus two doses of ivermectin for the control of scabies using a mass drug administration strategy (the RISE study) by Michael Marks, John Kaldor, Oliver Sokana, Tibor Schuster, Ross Andrews, Susanna J Lake, Sophie L Phelan, Daniel Engelman, Titus Nasi, Dickson Boara, Christina Gorae, Anneke C Grobler, Millicent H Osti, Margot J Whitfeld, Lucia Romani, Andrew Steer

    Published 2020-08-01
    Get full text
    Article
  10. 10
    10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial

    10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and s... by Jonathan Carapetis, Paul Torzillo, Heidi Smith-Vaughan, Tom Snelling, Mark Chatfield, Amanda Jane Leach, Ross Andrews, Kim Mulholland, Victor M Oguoma, Nicole Wilson, Peter McIntyre, Anne Balloch, Deborah Lehmann, Michael J Binks, Anne Chang, Vicki Krause, Paul Licciardi, Peter Morris

    Published 2020-05-01
    Get full text
    Article
  11. 11
    One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial.

    One versus two doses of ivermectin-based mass drug administration for the control of scabies: A cluster randomised non-inferiority trial. by Susanna J Lake, Daniel Engelman, Julie Zinihite, Oliver Sokana, Dickson Boara, Titus Nasi, Christina Gorae, Millicent H Osti, Sophie Phelan, Matthew Parnaby, Anneke C Grobler, Tibor Schuster, Ross Andrews, Margot J Whitfeld, Michael Marks, Lucia Romani, Andrew C Steer, John M Kaldor

    Published 2023-03-01
    Get full text
    Article
  12. 12
    Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial

    Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) sch... by Amanda Jane Leach, Edward Kim Mulholland, Mathuram Santosham, Paul John Torzillo, Peter McIntyre, Heidi Smith-Vaughan, Nicole Wilson, Beth Arrowsmith, Jemima Beissbarth, Mark D. Chatfield, Victor M. Oguoma, Paul Licciardi, Sue Skull, Ross Andrews, Jonathan Carapetis, Joseph McDonnell, Vicki Krause, Peter Stanley Morris

    Published 2021-04-01
    Get full text
    Article
  13. 13
    An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Protocol

    An Observational Study to Assess the Effectiveness of 4CMenB against Meningococcal Disease and Carriage and Gonorrhea in Adolescents in the Northern Territory, Australia—Study Prot... by Helen S. Marshall, Prabha H. Andraweera, James Ward, John Kaldor, Ross Andrews, Kristine Macartney, Peter Richmond, Vicki Krause, Ann Koehler, David Whiley, Lynne Giles, Rosalind Webby, Heather D’Antoine, Jonathan Karnon, Rob Baird, Andrew Lawrence, Helen Petousis-Harris, Philippe De Wals, Belinda Greenwood-Smith, Michael Binks, Lisa Whop

    Published 2022-02-01
    Get full text
    Article

Search Tools: